Starts in 2 months from now
Locationonline
ProgrammesThis information webinar on the European Research Council (ERC) Advanced Grant call for proposals 2025 is organised by the National Contact Points (NCPs) for ERC in Belgium (NCP Federal BE, NCP Flanders and NCP-FNRS) to inform potential applicants and host institutions. It is also aimed at researchers who are considering applying in the future.
The ERC Advanced Grant Call 2025 opening indicative date is 22/05/2025 with a deadline on 28 August 2025. The 2025 ERC Advanced Grant call will be made available on the European Commission Funding and Tender Portal.
The call will be open to established research leaders of any nationality and from any field of research (bottom-up approach), with a recognized track-record of research achievements. There is no minimum or maximum age limit. The amount of the grant is up to € 2.5 million for 5 years (or up to €3.5 million in specific cases). This is a lump-sum call. Last year’s call was a pilot on the use of lump sum contribution and thus the following related resources could be useful for the time being: Q&A on lump sums and webinar on lump sums .
Participation to this webinar is free but restricted to researchers wishing to apply with a Belgian host institution, or staff members of Belgian host institutions. Registration is mandatory.
The registration form of the webinar, which is available also via this webpage.
Programme of the webinar
10.00 Welcome
10.05 Overview on the ERC Advanced Grant call
10.35 Questions & Answers
11.00 Perspectives from a grant holder including Questions & Answers
11.20 Perspectives from a panel member including Questions & Answers
11.45 End of the webinar
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health Digital, Industry & Space Climate, Energy, Mobility AI, data & cloud Deployment: Best use of technologies
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.